These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 18974610)

  • 21. Potential role of intestinal first-pass metabolism in the prediction of drug-drug interactions.
    Galetin A; Gertz M; Houston JB
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):909-22. PubMed ID: 18624679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel approach to the prediction of drug-drug interactions in humans based on the serum incubation method.
    Shibata Y; Takahashi H; Chiba M; Ishii Y
    Drug Metab Pharmacokinet; 2008; 23(5):328-39. PubMed ID: 18974610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents.
    Hsu A; Granneman GR; Bertz RJ
    Clin Pharmacokinet; 1998 Oct; 35(4):275-91. PubMed ID: 9812178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
    Wilkinson GR
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maximal inhibition of intestinal first-pass metabolism as a pragmatic indicator of intestinal contribution to the drug-drug interactions for CYP3A4 cleared drugs.
    Galetin A; Hinton LK; Burt H; Obach RS; Houston JB
    Curr Drug Metab; 2007 Oct; 8(7):685-93. PubMed ID: 17979656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.
    Williams JA; Hyland R; Jones BC; Smith DA; Hurst S; Goosen TC; Peterkin V; Koup JR; Ball SE
    Drug Metab Dispos; 2004 Nov; 32(11):1201-8. PubMed ID: 15304429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.
    Sahi J; Grepper S; Smith C
    Curr Drug Discov Technol; 2010 Sep; 7(3):188-98. PubMed ID: 20843293
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.